Groundbreaking CAR T Cell Therapy for Multiple Sclerosis: UK Patient Receives First Treatment

In a historic first, a UK patient with multiple sclerosis (MS) has received CAR T cell therapy as part of a groundbreaking clinical trial. Emily Henders, a 37-year-old biology teacher from Hertfordshire, shares her hopeful journey and the potential of this experimental treatment to halt MS progression. Learn how CAR T cell therapy, originally developed for blood cancer, is being adapted to target autoimmune conditions like MS. This video explores the science behind the therapy, the trial's goals, and the impact it could have on the 150,000+ MS patients in the UK. Discover how researchers at UCL and UCLH are pioneering this innovative approach, aiming for long-term remission with a single treatment. Stay informed about the latest advancements in MS treatment and the future of personalized medicine. #MultipleSclerosis #CARTCellTherapy #MedicalBreakthrough #MSResearch #UCL #UCLH #AutoimmuneDisease